The following are key points to remember from the 2024 European Society of Cardiology (ESC) guidelines for the management of elevated blood pressure (BP) and hypertension: ...
In this week’s View, Dr. Eagle looks at the kidney and cardiovascular effectiveness of SGLT2 inhibitors versus GLP-1 receptor agonists in type 2 diabetes. He then explores the prognostic ability of ...
Hypertension remains the leading global cause of death and disability, with more than half of hypertensive individuals in the U.S. failing to meet guideline-directed blood pressure (BP) targets. This ...
The following are key points to remember from a state-of-the-art review on management of patients with coexisting atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF): ...
Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...
The following are key points to remember from the 2024 European Society of Cardiology (ESC) guidelines for the management of peripheral arterial and aortic diseases: ...
In patients with high-risk atrial fibrillation (AFib) and stable coronary artery disease, endoxaban monotherapy when given as a long-term antithrombotic therapy was associated with better net clinical ...
In patients with an ACS on maximal tolerated statin randomized to the PCSK9 inhibitor alirocumab vs. placebo, baseline triglyceride levels predicted MACE, even after adjustment for covariates ...
In this week’s View, Dr. Eagle looks at the 2024 ACC/AHA key data elements and definitions for social determinants of health in cardiology. He then explores key points of management of aortopathy in ...
The INFINITY-SWEDEHEART trial showed that in patients undergoing PCI for chronic or acute coronary syndrome, the DynamX bioadaptor resulted in less target lesion and vessel failure compared with the ...
In this interview, Vidhu Anand, MD, FACC, and Alison L. Bailey, MD, FACC, provide a comprehensive exploration of Low Flow-Low Gradient Aortic Stenosis, shedding light on its definition and exploring ...
Porcari A, Masi A, Martinez-Naharro A, et al. This study analyzed all patients with AL amyloidosis from a prospective registry of newly diagnosed patients at the National Amyloidosis Center in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback